Prelude Capital Management’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Prelude Capital Management's ADRX Position: Q3 2026 in Review
Prelude Capital Management opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 38,800 shares worth $774K. The stake represents 0.06% of the portfolio and ranks #390 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Prelude Capital Management held 38,800 shares of ADARx Pharmaceuticals worth $774K as of Q3 2026.
- ADARx Pharmaceuticals was a new Prelude Capital Management position in Q3 2026.
- ADARx Pharmaceuticals made up 0.06% of Prelude Capital Management's portfolio in Q3 2026, its #390 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.